Issue navigation
Volume 21, Issue 4, April 2019
Editorials
Risk factor modification: another win for our fight against atrial fibrillation
Lin Y Chen and Mina K Chung
EP Europace, Volume 21, Issue 4, April 2019, Pages 527–528, https://doi.org/10.1093/europace/euz010
Commentary: Cryoballoon vs. radiofrequency ablation for atrial fibrillation—a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry
Laura Rottner and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 529–530, https://doi.org/10.1093/europace/euy259
To continue or minimally interrupt direct oral anticoagulants around ablation for atrial fibrillation: that is the question
David H Birnie
EP Europace, Volume 21, Issue 4, April 2019, Pages 531–532, https://doi.org/10.1093/europace/euy278
Cryoablation vs. radiofrequency for therapy of atrioventricular nodal re-entrant tachycardia
Demosthenes G Katritsis
EP Europace, Volume 21, Issue 4, April 2019, Pages 533–534, https://doi.org/10.1093/europace/euy249
The challenges of implanted cardiac device security: lessons from recent compromises
G Stuart Mendenhall
EP Europace, Volume 21, Issue 4, April 2019, Pages 535–538, https://doi.org/10.1093/europace/euy264
Reviews
Reducing right ventricular pacing burden: algorithms, benefits, and risks
Lior Jankelson and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 539–547, https://doi.org/10.1093/europace/euy263
Half a century of continuous pacing: a living witness to the evolution of a technology
Banu Evranos and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 548–553, https://doi.org/10.1093/europace/euy218
Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on?
Aaron O Koshy and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 554–562, https://doi.org/10.1093/europace/euy299
Clinical Research
Atrial fibrillation
Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study
Ruben R De With and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 563–571, https://doi.org/10.1093/europace/euy311
The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Naja Emborg Vinding and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 572–580, https://doi.org/10.1093/europace/euy262
Ablation for atrial fibrillation
Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry
David Mörtsell and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 581–589, https://doi.org/10.1093/europace/euy239
Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy
Tomoyuki Nagao and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 590–597, https://doi.org/10.1093/europace/euy224
Comparison between linear and focal ablation of complex fractionated atrial electrograms in patients with non-paroxysmal atrial fibrillation: a prospective randomized trial
Kwang-No Lee and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 598–606, https://doi.org/10.1093/europace/euy313
Sudden death and ICDs
Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry
Tilman Perrin and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 607–615, https://doi.org/10.1093/europace/euy284
Ablation for ventricular tachycardia
Prolonged action potential duration and dynamic transmural action potential duration heterogeneity underlie vulnerability to ventricular tachycardia in patients undergoing ventricular tachycardia ablation
Neil T Srinivasan and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 616–625, https://doi.org/10.1093/europace/euy260
Pacing and cardiac resynchronization therapy
Integration of cardiac magnetic resonance imaging, electrocardiographic imaging, and coronary venous computed tomography angiography for guidance of left ventricular lead positioning
Uyên Châu Nguyên and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 626–635, https://doi.org/10.1093/europace/euy292
Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial
Giuseppe Boriani and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 636–644, https://doi.org/10.1093/europace/euy286
Leads and lead extraction
Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis
Luca Segreti and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 645–654, https://doi.org/10.1093/europace/euy307
Cardiac electrophysiology and ablation
Acute safety, effectiveness, and real-world clinical usage of ultra-high density mapping for ablation of cardiac arrhythmias: results of the TRUE HD study
Gerhard Hindricks and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 655–661, https://doi.org/10.1093/europace/euy191
Cryoablation with an 8-mm tip catheter in the treatment of atrioventricular nodal re-entrant tachycardia: results from a randomized controlled trial (CRYOABLATE)
Ngai-Yin Chan and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 662–669, https://doi.org/10.1093/europace/euy225
Young EP
Survey on the research activities within the EHRA Young EP community
Kevin Vernooy and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 670–672, https://doi.org/10.1093/europace/euy294
Technical Issues
Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy
Keping Chen and others
EP Europace, Volume 21, Issue 4, April 2019, Pages 673–680, https://doi.org/10.1093/europace/euy252
EP Case Express
Leadless pacemaker implantation via azygos vein in a patient with absence of the hepatic segment of the inferior vena cava
Mário Oliveira and others
EP Europace, Volume 21, Issue 4, April 2019, Page 547, https://doi.org/10.1093/europace/euy274
A case of focal ventricular tachycardia with alternating endocardial and epicardial exits: utility of non-invasive mapping in predicting exits
Arber Kodra and others
EP Europace, Volume 21, Issue 4, April 2019, Page 580, https://doi.org/10.1093/europace/euy241
Chylothorax and chylopericardium as unusual manifestation of pacing lead related complication
Anna Polewczyk and others
EP Europace, Volume 21, Issue 4, April 2019, Page 644, https://doi.org/10.1093/europace/euy269
Letters to the Editor
Ventricular depolarization limited to proximal septum: by which pathway?
Goran Milicevic
EP Europace, Volume 21, Issue 4, April 2019, Page 681, https://doi.org/10.1093/europace/euy271
Level of block: atrioventricular node, infra-Hisian, or intramyocardial?—Authors’ reply
Deepak Padmanabhan and others
EP Europace, Volume 21, Issue 4, April 2019, Page 682, https://doi.org/10.1093/europace/euy319
Erratum
Erratum to: Cryoablation with an 8-mm tip catheter in the treatment of atrioventricular nodal re-entrant tachycardia: results from a randomized controlled trial (CRYOABLATE)
EP Europace, Volume 21, Issue 4, April 2019, Page 669, https://doi.org/10.1093/europace/euy302
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals